Modification of albendazole pharmacokinetics by menbutone administration in calves
E. Milena Vazquez, Beatriz Romero, Raquel Diez, Cristina Lopez, Jose M. Rodriguez, Nelida Fernandez, M. Jose Diez, Ana M. Sahagun · 2026
Read Modification of albendazole pharmacokinetics by menbutone administration in calves by E. Milena Vazquez, Beatriz Romero, Raquel Diez, Cristina Lopez, Jose M. Rodriguez, Nelida Fernandez, M. Jose Diez, Ana M. Sahagun (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13193926.txt.
Description
Vazquez and seven co-authors test whether a bile-flow drug boosts a dewormer's active form in calves, in a study from twenty twenty-six. Worm resistance is spreading while new antiparasite drugs arrive slowly, so squeezing more from existing ones matters. The dewormer albendazole works through a breakdown product formed in the body.
Twelve calves got the dewormer alone or with one or two doses of the bile drug menbutone. Blood tracked over three days showed the parent drug never appeared, while the active product lingered. One menbutone dose raised the active product's peak and total exposure by about a third. A second dose added nothing. The inactive end product stayed unchanged throughout.
Catalog record
| CREATOR | E. Milena Vazquez, Beatriz Romero, Raquel Diez, Cristina Lopez, Jose M. Rodriguez, Nelida Fernandez, M. Jose Diez, Ana M. Sahagun |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |